Abstract:Introduction: The benefit of cognitive rehabilitation (CR) for patients with early-stage Alzheimer disease (AD) remains difficult to assess. Method: An observational, prospective study was conducted in a sample of 52 patients with AD included in a clinical, individualized CR program. Cognitive rehabilitation consisted of 1 weekly session during 3 months at home, followed by 1 monthly contact for 9 months. Rehabilitation techniques were used by experienced therapists to adapt activities important for the patien… Show more
“…Measuring the benefit of CR for caregivers remains quite difficult. 8 As in our previous study, 21 and contrary to a recent RCT, 7 we could not demonstrate any benefit on caregiver's burden with the classical Zarit burden interview. 16 However, the score on this scale did not increase in the CR group despite an increase in global cognitive impairment.…”
Section: Discussioncontrasting
confidence: 92%
“…The procedure is illustrated elsewhere. 21 Briefly, the caregiver had to identify and estimate the difficulties in 98 daily life activities. The total score corresponded to the severity of reported difficulties, with 0 point if no difficulties, 1 point for lack of activity initiation, omission of one or several steps, or wrong execution of one or several steps (maximum 3 points), 4 points corresponding to perseveration errors, and 5 points if the activity could not be carried out; points were summed over all the assessed activities and expressed in percentage of the maximal dependency score.…”
Introduction: Assessing the benefit of cognitive rehabilitation (CR) remains difficult. Method: An observational study was conducted in 33 patients with early-stage Alzheimer disease and their caregiver included in a clinical CR program at home, compared to 17 patients who received usual treatment. Evaluation of patient’s dependence and objective and subjective caregiver’s burden was performed by the caregiver with a research tool focusing on impairment in daily activities related to cognitive deficits. Results: Repeated measures analysis of variance showed a time by group interaction ( P < .05), with decreased patient’s dependence for adapted activities at 1 year in the CR group. Lawton scale for daily activities showed also a time by group interaction ( P < .05), with increased dependence at 1 year in the control group. There was a significant decrease in Mini-Mental State Examination scores in both groups at 1-year follow-up ( P < .05). Concerning caregiver’s subjective burden, there was a trend for the time by group interaction ( P = .07), and post hoc Tukey test showed that subjective burden was decreased in the CR group ( P < .05). This was confirmed by nonparametric Mann-Whitney analysis on differences between follow-up and baseline evaluation ( P < .05). Conclusion: This observational study in a clinical setting is in line with the benefit of CR reported in recent randomized controlled trials. The benefit obtained for adapted daily activities remained after 1 year, even if global cognition declined. Moreover, caregiver’s subjective burden related to all relevant daily activities evaluated within the CR program was decreased after 1 year in our clinical setting.
“…Measuring the benefit of CR for caregivers remains quite difficult. 8 As in our previous study, 21 and contrary to a recent RCT, 7 we could not demonstrate any benefit on caregiver's burden with the classical Zarit burden interview. 16 However, the score on this scale did not increase in the CR group despite an increase in global cognitive impairment.…”
Section: Discussioncontrasting
confidence: 92%
“…The procedure is illustrated elsewhere. 21 Briefly, the caregiver had to identify and estimate the difficulties in 98 daily life activities. The total score corresponded to the severity of reported difficulties, with 0 point if no difficulties, 1 point for lack of activity initiation, omission of one or several steps, or wrong execution of one or several steps (maximum 3 points), 4 points corresponding to perseveration errors, and 5 points if the activity could not be carried out; points were summed over all the assessed activities and expressed in percentage of the maximal dependency score.…”
Introduction: Assessing the benefit of cognitive rehabilitation (CR) remains difficult. Method: An observational study was conducted in 33 patients with early-stage Alzheimer disease and their caregiver included in a clinical CR program at home, compared to 17 patients who received usual treatment. Evaluation of patient’s dependence and objective and subjective caregiver’s burden was performed by the caregiver with a research tool focusing on impairment in daily activities related to cognitive deficits. Results: Repeated measures analysis of variance showed a time by group interaction ( P < .05), with decreased patient’s dependence for adapted activities at 1 year in the CR group. Lawton scale for daily activities showed also a time by group interaction ( P < .05), with increased dependence at 1 year in the control group. There was a significant decrease in Mini-Mental State Examination scores in both groups at 1-year follow-up ( P < .05). Concerning caregiver’s subjective burden, there was a trend for the time by group interaction ( P = .07), and post hoc Tukey test showed that subjective burden was decreased in the CR group ( P < .05). This was confirmed by nonparametric Mann-Whitney analysis on differences between follow-up and baseline evaluation ( P < .05). Conclusion: This observational study in a clinical setting is in line with the benefit of CR reported in recent randomized controlled trials. The benefit obtained for adapted daily activities remained after 1 year, even if global cognition declined. Moreover, caregiver’s subjective burden related to all relevant daily activities evaluated within the CR program was decreased after 1 year in our clinical setting.
“…This decline was lower compared to the average annual rate of change with no treatment reported by other studies: 3.6 points [42], 2.3 points [37], and 2.2 points [13]. Germain et al [43] observed a two-point decrease in the MMSE from baseline to twelve months in AD patients subjected to cognitive rehabilitation.…”
Research has shown that non-pharmacological therapies can be useful in the treatment of Alzheimer’s disease (AD), significantly delaying cognitive decay. However, most AD interventions did not last beyond six months. Hence, little is known about the effect of these programs in the AD patients after six months of treatment. The purpose of this study was to evaluate the efficacy of the twelve-month Comprehensive Program of Cognitive Training (CPCT) for a sample of AD patients and to compare the results with the average annual rate of change. Thirty-nine AD patients participated in the study. The CPCT consists of a set of cognitive stimulations, intervention in activities of daily life (ADL), and motor training for 12 months. All patients were evaluated at baseline and in three-month intervals via the Mini Mental State Examination (MMSE), the Cambridge Cognitive Examination (CAMCOG), the Lawton Instrumental Activities of Daily Living Scale (IADL), and the Global Deterioration Scale (GDS). After CPCT implementation, there were no significant differences in the MMSE, IADL, and GDS evaluations between baseline and twelve months. Concerning the CAMCOG evaluation, there was no significant difference between the baseline and sixth-month assessments. Overall, the participants’ cognitive functioning did not decline when compared to the average annual rate of change. The CPCT extends the benefit of non-pharmacological interventions for AD patients to twelve months. Its implementation might provide the patients’ relatives with some guarantee concerning the delay of the disease. Future research may investigate the efficacy of the CPCT in comparison with a control group and over a more extended period.
“…Ayrıca bu hastaların bakım verenlerinin duygusal tükenmişliğinde kontrollere göre artma olmadığı ve hatta 1 yıl sonraki günlük aktivitelerle ilişkili bakım veren tükenmişliğinde azalma olduğu gösterilmiştir. 25 BR, aynı zamanda yaşam kalitesini iyileştiren ve sağlık kurumuna yatışı geciktiren uygulanabilir bir yaklaşımdır. 26,27 AH sürecinin önemli bir parçası hastaların %90-98'inde görülen, davranışsal ve psikiyatrik belirtilerdir.…”
Section: Erken Evre Alzheimer Hastaliğinda Bi̇li̇şsel Rehabi̇li̇tasyonunclassified
Alzheimer hastalığı (AH), bilişsel ve sosyal işlevselliği etkileyen ilerleyici seyirli nörodejeneratif bir hastalıktır. Tüm demansların en az %60'ını oluşturur. 1 Yaşlı nüfusta, yaşla ilişkili insidans her 5,5 yılda 2'ye katlar. 2050 yılında dünyadaki Alzheimer hastası sayısının 115,4 milyon kişi olacağı tahmin edilmektedir. 2 Türkiye'de 70 yaş üstü kişilerin değerlendirildiği bir çalışmada muhtemel AH sıklığı
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.